Out of UC Berkeley, a small molecule called TOFA has emerged as a quiet but consequential challenge to the reigning logic of obesity medicine — not by silencing hunger, but by coaxing the body to burn what it carries. In obese mice, the compound produced an 18 percent reduction in body weight while sparing muscle, and when paired with the GLP-1 drugs already reshaping clinical practice, it amplified fat loss beyond what either approach achieved alone. The finding does not yet touch a single human life, but it reframes an old question: rather than asking how to make people eat less, it asks wha